Treatment consideration and manifest complexity in comorbid neuropsychiatric disorders

Neurotoxicity Research

Volumn 12, Issue 1, 2007, Pages 43-60

  Palomo, Tomas ^a   Kostrzewa, Richard M ^b   Beninger, Richard J ^c   Archer, Trevor ^d,e  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b East Tennessee State University   (United States)

^c QUEEN S UNIVERSITY   (Canada)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e LINNAEUS UNIVERSITY   (Sweden)

Author keywords

Affective; Comorbidity; Epilepsy; Impulsivity; Neuropsychiatry; Obsessive compulsive; Psychosis; Schizophrenia; Substance abuse; Symptoms; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; CLOZAPINE; LADOSTIGIL; LEVODOPA; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; RITANSERIN; TIANEPTINE;

ALCOHOLISM; ALZHEIMER DISEASE; ARTICLE; BIPOLAR DISORDER; COMORBIDITY; DEPRESSION; DIFFUSE LEWY BODY DISEASE; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; ELECTROCONVULSIVE THERAPY; EPILEPSY; HUMAN; IMPULSIVENESS; MENTAL DISEASE; MOOD DISORDER; MOTOR DYSFUNCTION; NEUROPSYCHIATRY; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SUBSTANCE ABUSE; SYMPTOM; TARDIVE DYSKINESIA; TOBACCO DEPENDENCE; TREATMENT PLANNING; IATROGENIC DISEASE; NEUROLOGIC DISEASE; PERSONALITY; PREVALENCE; REVIEW;

COMORBIDITY; HUMANS; IATROGENIC DISEASE; IMPULSIVE BEHAVIOR; MENTAL DISORDERS; MOVEMENT DISORDERS; NERVOUS SYSTEM DISEASES; OBSESSIVE-COMPULSIVE DISORDER; PERSONALITY; PREVALENCE; SCHIZOPHRENIA;

EID: 34548633297     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033900     Document Type: Article

References (241)

1. Addington J and D Addington (1998) The effect of substance abuse in early psychosis. Psychiatr. Serv. 49, 925-928.
2. Akbarian S, JJ Kim, SG Potkin et al. (1995) Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen Psychiatry 52, 258-266.
3. Albanese MJ, EJ Khantzian, SL Murphy and AI Green (1994) Decreased substance use in chronically psychotic patients treated with clozapine [letter]. Am. J. Psychiatry 151, 780-781.
4. Albertson TE, RM Joy and LG Stark (1984) Carbamazepine: A pharmacological study in the kindling model of epilepsy. Neuropharmacology 23, 1117-1124.
5. Allcock CC and DM Grace (1988) Pathological gamblers are neither impulsive nor sensation-seekers. Aust. NZ J. Psychiatry 22, 307-311.
6. Allen TJ, EG Moeller, HM Rhoades and DR Cherek (1998) Impulsivity and history of drug dependence. Drug Alcohol Depend. 50, 137-145.
7. Anderson SW, A Bechara, H Damasio, D Tranel and AR Damasio (1999) Impairment of social and moral behaviour related to early damage in human prefrontal cortex. Nat. Neurosci. 2, 1032-1037.
8. Archer T, G Jonsson, BG Minor and C Post (1986) Noradrenergic-serotonergic interactions and nociception in the rat. Eur. J. Pharmacol. 120, 295-307.
9. Askenazy FL, K Sorci, M Benoit, K Lestideau, M Myquel and Y Lecrubier (2003) Anxiety and impulsivity levels identify relevant subtypes in adolescents with at-risk behaviour. J. Affect. Disord. 74, 219-227.
10. Ball SA (2001) Reconceptualizing personality disorder categories using personality trait dimensions: Introduction to special section. J. Personal. 69, 147-153.
11. Ball SA, H Tennen, JC Poling, HR Kranzler and BJ Rounsaville (1997) Personality, temperament and character dimensions in substance abusers. J. Abnorm. Psychol. 106, 545-553.
12. Barratt ES (1965) Factor analysis of some psychometric measures of impulsiveness and anxiety. Psychol. Rev. 16, 547-554.
13. Barratt ES (1985) Impulsiveness subtraits: Arousal and information processing, In: Motivation, Emotion and Personality (Spence JT and CE Izard, Eds.) (Elsevier: New York), pp. 137-143.
14. Barratt ES and J Patton (1983) Impulsivity: Cognitive, behavioral and psychophysiological correlates, In: Biological Bases of Impulsivity and Sensation Seeking (Zuckerman M, Ed.) (Erlbaum: Hillsdale, NJ), pp. 77-122.
15. Barratt ES, MS Stanford, TA Kent and A Felthous (1997) Neuropsychological and cognitive psychophysiological substrates of impulsive aggression. Biol. Psychiatry 41, 1045-1061.
16. Barrowclough C (2007) Co-morbid psychosis and substance abuse, In: Comorbidity in Neuropsychiatric Disorders (Palomo T, RJ Beninger, RM Kostrzewa and T Archer, Eds.) (Fundacion Cerebroy Mente: Madrid) (in press).
17. Bastani B, RC Arora and HY Meltzer (1991) Serotonin uptake and imipramine binding in the blood platelets of obsessive-compulsive patients. Biol. Psychiatry 30, 131-139.
18. Bechara A, H Damasio and D Tranel (1997) Deciding advantageously before knowing the advantageous strategy. Science 275, 1293-1295.
19. Beninger RJ (2006) Dopamine and incentive learning: A framework for considering antipsychotic medication effects. Neurotox. Res. 10, 1-11.
20. Beninger RJ, JI Wassreman, K Zanibbi, D Charbonneau, J Mangels and BV Beninger (2003) Typical and atypical antipsychotic medications differentially affect two nondeclarative memory tasks in schizophrenic patients: A double dissociation. Schizophr. Res. 61, 281-292.
21. Berlin HA, ET Rolls and U Kischka (2004) Impulsivity, time perception, emotion and reinforcement sensitivity in patients with orbitofrontal cortex lesions. Brain 127, 1108-1126.
22. Blair RJR (1995) A cognitive developmental approach to mortality: investigating the psychopathy. Cognition 57, 1-29.
23. Blair RJR (2001) Neuro-cognitive models of aggression, the antisocial personality disorders and psychopathy. J. Neurol. Neurosurg. Psychiatry 71, 727-731.
24. Blair RJR (2003) Neurobiological basis of psychopathy. Br. J. Psychiatry 182, 5-7.
25. Blair RJ, JS Morris, CD Frith, DI Perrett and RJ Dolan (1999) Dissociable neural responses to facial expressions of sadness and anger. Brain 122, 883-893.
26. Blanco C, L Orensanz-Munoz, C Blanco-Jerez and J Saiz-Ruiz (1996) Pathological gambling and platelet MAO activity: A psychobiological study. Am. J. Psychiatry 153, 119-121.
27. Blaszczynski AP, Z Steel and N McConaghy (1997) Impulsivity in pathological gambling: The antisocial impulsivist. Addiction 92, 75-87.
28. Bolwig (2007) Epilepsy and affective disorder: Clinical manifestations and pathophysiological considerations, In: Comorbidity in Neuropsychiatric Disorders (Palomo T, RJ Beninger, RM Kostrzewa and T Archer, Eds.) (Fundacion Cerebroy Mente: Madrid) (in press).
29. Bond AJ, SL Verheyden, J Wingrove and HV Curran (2004) Angry cognitive bias, trait aggression and impulsivity in substance users. Psychopharmacology 171, 331-339.
30. Bood S-Å, T Archer and T Norlander (2004) Affective personality in relation to general personality, self-reported stress, coping and optimism. Ind. Diff. Res. 2, 26-37.
31. Borsini F and A Meli (1988) Is the forced swimming test a suitable model for revealing antidepressant activity. Psychopharmacology 94, 147-160.
32. Braak H and E Braak (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239-259.
33. Brady KT, H Myrick and S McElroy (1998) The relationship between substance abuse disorders, impulse control disorders, and pathological aggression. Am. J. Addict. 7, 221-230.
34. Brent DA, BA Johnson, J Perper, J Connolly, J Bridge, S Bartle and C Rather (1994) Personality disorder, personality traits, impulsive violence, and completed suicide in adolescents. J. Am. Acad. Child Adolesc. Psychiatry 33, 1080-1086.
35. Carlton PL and P Manowitz (1994) Factors affecting the severity of pathological gamblers in males. J. Gambling Stud. 10, 147-157.
36. Castellani B and L Rugle (1995) A comparison of pathological gamblers to alcoholics and cocaine misusers on impulsivity, sensation-seeking, and craving. Int. J. Addict. 30, 275-289.
37. Cavedini P, G Riboldi, R Keller, A D'Annucci and L Bellodi (2002) Frontal lobe dysfunction in pathological gambling patients. Biol. Psychiatry 51, 334-341.
38. Chambers RA, JR Taylor and MN Potenza (2003) Developmental neurocircuitry of motivation in adolescence: A critical period of addiction vulnerability. Am. J. Psychiatry 160, 1041-1052.
39. Cloninger CR (1999) Temperament and Character Inventory - Revised (St. Louis Center for Psychology of Personality, Washington University: St. Louis, MO).
40. Cloninger CR, DM Svrakic and TR Przybeck (1993) A psychobiological model of temperament and chatracter. Arch. Gen. Psychiatry 50, 975-990.
41. Coccaro EF (1989) Central serotonin and impulsive aggression. Br. J. Psychiatry 155, 52-62.
42. Combs DR and C Advocat (2000) Antipsychotic medication and smoking prevalence in acutely hospitalised patients with chronic schizophrenia. Schizophr. Res. 24, 129-137.
43. Convit A, P Czober and J Volavka (1991) Lateralized abnormality in the EEG of persistently violent psychiatric inpatients. Biol. Psychiatry 3, 121-138.
44. Cools R, A Blackwell, L Clark, L Menzies, S Cox and TW Robbins (2005) Tryptophan depletion disrupts the motivational guidance of goal-directed behavior as a function of trait impulsivity. Neuropsychopharmacology 30, 1362-1373.
45. Corruble E, C Damy and JD Guelfi (1999) Impulsivity: A relavant dimension in depression regarding suicide attempts? J. Affect. Disord. 53, 211-215.
46. Corruble E, A Benyamina, F Bayle, B Falissard and P Hardy (2003) Understanding impulsivity in severe depression? A psychometrical contribution. Prog. Neuropsychopharmacol. Biol. Psychiatry 27, 829-833.
47. Coyle JT (2006) Substance use disorders and schizophrenia: A question of shared glutamatergic mechanisms. Neurotox Res. 10(3-4), 221-233. Review.
48. Curtis VA, ET Bullmore, RG Morris et al. (1999) Attenuated frontal activation in schizophrenia may be task dependent. Schizophr. Res. 37, 35-44.
49. Dalack GW and JH Meador-Woodruff (1996) Smoking, smoking withdrawal and schizophrenia: Case reports and a review of the literature. Schizophr. Res. 22, 133-141.
50. Dalack GW, DJ Healy and JH Meador-Woodruff (1998) Nicotine dependence in schizophrenia: Clinical phenomena and laboratory findings. Am. J. Psychiatry 155, 1490-1501.
51. Dalack GW, L Becks, E Hill, OF Pomerleau and JH Meador-Woodruff (1999) Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia. Neuropsychopharmacol. 21, 195-202.
52. DeCaria CM, E Hollander, R Grossman, CM Wong, SA Mosivich and S Cherkasky (1996) Diagnosis, neurobiology, and treatment of pathological gamblers. J. Clin. Psychiatry 57(Suppl. 8), 80-84.
53. 2 receptors by antipsychotic drugs is related to nicotine addiction in young patients. Psychopharmacology 183, 500-505.
54. Dikman ZV and JJ Allen (2000) Error monitoring during reward and avoidance learning in high- and low-socialized individuals. Psychophysiology 37, 43-54.
55. Dolan M, WJF Deakin, N Roberts and I Anderson (2002) Serotonergic and cognitive impairment in impulsive aggressive personality disordered offenders: Are their implications for treatment? Psychol. Med. 32, 105-117.
56. Dougherty DM, JM Bjork, HC Huckabee, FG Moeller and AC Swann (1999) Laboratory measures of aggression and impulsivity in women with borderline personality disorder. Psychiatry Res. 85, 315-326.
57. Dougherty DM, JM Bjork, RA Harper, DM Marsh, FG Moeller, CW Mathias and AC Swann (2003) Behavioral impulsivity paradigms: A comparason in hospitalized adolescents with disruptive behavior disorders. J. Child Psychol. Psychiatry 44, 1145-1157.
58. Drake ME, SA Hietter and A Pakalnis (1992) EEG and evoked potentials in episodic dyscontrol syndrome. Neuropsychobiol. 26, 125-128.
59. Drake RE, KT Mueser, MF Brunette and GJ McHugo (2004) A review of treatments for people with severe mental illnesses and co-occuring substance abuse disorders. Psychiatr. Rehabil. J. 27, 360-374.
60. Drevets WC, JL Price, ME Bardgett, T Reich, RD Todd and ME Raichle (2002) Glucose metabolism in the amygdale in depression: Relationship to diagnostic subtype and plasma cortisol levels. Pharmacol. Biochem. Behav. 71, 431-447.
61. Dupin N, F Mailliet, C Rocher, K Kessal, M Spedding and TM Jay (2006) Common efficacy of psychotropic drugs in restoring stress-induced impairment of prefrontal plasticity. Neurotox. Res. 10(3,4), 193-198.
62. Eisen JL, DA Beer, MT Pato, TA Venditto and SA Rasmussen (1997) Obsessive-compulsive disorder in patients with schizophrenia and schizoaffective disorder. Am. J. Psychiatry 154, 271-273.
63. Ekselius L, E Lindström, L Von Knorring and O Bondulund (1994) Comorbidity among the personality disorders in DSM-IIIR. Pers. Individ. Differ. 17, 545-553.
64. Els C (2004) What is the role of pharmacotherapy in tobacco cessation in patients with schizophrenia? J. Psychiatry Neurosci. 29, 240-244.
65. Evenden JL (1999) Varieties of impulsivity. Psychopharmacology 146, 348-361.
66. Farrington DP (1997) The relationship between low resting heart rate and violence, In: Biological Bases of Violence (Raine A, PA Brennan, DP Farrington and SA Mednick, Eds.) (Plenum: New York), pp. 89-105.
67. Fawcett J, KA Busch, D Jacobs, HM Kravitz and L Fogg (1997) Suicide: A four-pathway clinical-biochemical model. Ann. NY Acad. Sci. 836, 288-301.
68. Finberg JP, I Lamensdorf, JW Commissiong and MBH Youdim (1996) Pharmacology and neuroprotective properties of rasagiline. J. Neural Transm. Suppl. 48, 95-101.
69. Fishbein DH, RJ Herning, WB Pickworth, CA Haertzen, JE Hickey and JH Jaffe (1989) EEG and brainstem auditory evoked response potentials in adult male drug abusers with self-reported histories of aggressive behaviour. Biol. Psychiatry 25, 595-611.
70. Fletcher PC, F Happe, U Frith, SC Baker, RJ Dolan, RS Frackowiak and CD Frith (1995) Other minds in the brain: A functional imaging study of "theory of mind" in story comprehension. Cognition 57, 109-128.
71. Fossati A, C Maffei, M Bagnato, M Battaglia, D Donati and M Donini (2000) Patterns of covariation of DSM-IV personality disorders in a mixed psychiatry sample. Comprehen. Psychiatry 41, 206-215.
72. Fossati A, A Di Ceglie, E Acquarini and ES Barratt (2001) Psychometric properties of an Italian version of the Barratt Impulsiveness Scale-11 (BIS-11) in non-clinical subjects. J. Clin. Psychol. 57, 815-828.
73. Fossati A, C Maffei, E Acquarini and A Di Ceglie (2003) Multi-group confirmatory component and the factor analyses of Italian version of the Aggression Questionaire. Eur. J. Psychol. Assess. 19, 54-65.
74. Fossati A, ES Barratt, S Borroni, D Villa, F Grazioli and C Maffei (2006) Impulsivity, aggressiveness, and DSM-IV personality disorders. Psychiatry Res. 149(1-3), 157-167. Epub 2006 Dec 8.
75. Fuentes D, H Tavares, R Artes and C Gorenstein (2006) Self-reported and neuropsychological measures of impulsivity in pathological gambling. J. Int. Neuropsycholog. Soc. 12, 907-912.
76. Gabbard GO (2005) Mind, brain, and personality disorders. Am. J. Psychiatry 162, 648-655.
77. Gal S, H Zheng, M Fridkin and MBH Youdim (2005) Novel multifunctional neuroprotective chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion. J. Neurochem. 95, 79-88.
78. Gatzke-Kopp LM, A Raine, R Loeber, M Strouthamer and S Steinhauer (2002) Serious delinquent behavior, sensation seeking and electrodermal arousal. J. Abnorm. Child Psychol. 30, 477-486.
79. Gehring WJ and AR Willoughby (2002) The medial frontal cortex and the rapid processing of monetary gains and losses. Science 295, 2279-2282.
80. Gehring WJ, J Himle and LG Nisenson (2000) Action-monitoring dysfunction in obsessive-compulsive disorder. Psychol. Sci. 11, 1-6.
81. George TP, DM Ziedonis, A Feingold, WT Pepper, CA Satterburg, J Winkel, BJ Rounsaville and TR Kosten (2000) Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in patients with schiziphrenia. Am. J. Psychiatry 157, 1835-1842.
82. Gerstle JE, CW Mathias and MS Stanford (1998) Auditory P300 and self-reported impulsive aggression. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 22, 575-583.
83. Geyer MA (2006) The family of sensorimotor gating disorders: comorbidities or diagnostic overlaps? Neurotox. Res. 10, 1-10.
84. Goma-i-Freixanet M (1995) Prosocial and antisocial aspects of personality. Pers. Individ. Differ. 19, 125-134.
85. Gong L, RM Kostrzewa, RW Fuller and KW Perry (1992) Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system. J. Pharmacol. Exp. Ther. 261, 1000-1007.
86. Gong L, RM Kostrzewa, KW Perry and RW Fuller (1993) Dose-related effects of a neonatal 6-OHDA lesion on SKF-38393- and m-chlorophenylpiperazine-induced oral activity responses of rats. Dev. Brain Res. 76, 233-238.
87. Goveas JS, JG Csermansky and EF Coccaro (2004) Platelet serotonin content correlates inversely with life history of aggression in personality-disordered subjects. Psychiatr. Res. 126, 23-32.
88. Green AI (2006) Pharmacotherapy for schizophrenia and co-occuring substance abuse disorders. Neurotox. Res. 11, 1-7.
89. Green AI, MS Salomon, MJ Brenner and K Rawlins (2002) Treatment of schizophrenia and comorbid substance use disorder. Curr. Drug Targets CNS Neurol. Disord. 1, 129-139.
90. Green AI, ES Burgess, R Dawson, SV Zimmet and RD Strous (2003) Alcohol and cannabis use in schizophrenia: Effects of clozapine vs. risperidone. Schizophr. Res. 60, 81-85.
91. Green AI, MF Tohen, RM Hamer, SM Strakowski, JA Lieberman, I Glick, WS Clark and the HGDH Research Group (2004) First episode schizophrenia-related psychosis and substance use disorders: Acute response to olanzapine and haloperidol. Schizophr. Res. 66, 125-135.
92. Gualtieri CT (1995) The contribution of the frontallobes to a theory of psychopathology, In: Neuropsychiatry of Personality Disorders (Racey JJ, Ed.) (Blackwell: Cambridge, UK).
93. Hare RD (1978) Electrodermal and cardiovascular correlates of psychopathy, In: Psychopathic Behavior Approaches to Research (Hare RD and D Schalling, Eds.) (Wiley: New York), pp. 107-144.
94. Hare RD (1991) The Hare Psychopathy Checklist - Revised (Multi-Health Systems: Toronto, Ontario).
95. Hare RD, DJ Cooke and SD Hart (1999) Psychopathy and sadistic personality disorder, In: Oxford Textbook of Psychopathology (Millon T, PH Blaney and RD Davis, Eds.) (Oxford Univ. Press: London), pp. 555-584.
96. Hart SD and RD Hare (1996) Psychopathy and antisocial personality disorder. Curr. Opin. Psychiatry 9, 129-132.
97. Harvey PD, MH Serper, L White, MJ Parrella, SR McGurk, PJ Moriarty, C Bowie, N Vadhan, J Friedman and KL Davis (2001) The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia. Compr. Psychiatry 42, 306-313.
98. Haustein KO, S Haffner and BG Woodcock (2002) A review of the pharmacological and psychopharmacological aspects of smoking and smoking cessation in psychiatric patients. Int. J. Clin. Pharmacol. Ther. 40, 404-418.
99. Heckers S, SL Rauch, D Goff, CR Savage, DL Schacter, AJ Fischman and NM Alpert (1998) Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat. Neurosci. 1, 318-323.
100. Herran A, A de Santiago, M Sandoya, MJ Fernandez, JF Diez-Manrique and JL Vazquez-Barquero (2000) Determinants of smoking behaviour in outpatients with schizophrenia. Schizophr. Res. 41, 373-381.
101. Hester R and H Garavan (2004) Executive dysfunction in cocaine addiction: Evidence for discordant frontal, cingulate, and cerebellar activity. J. Neurosci. 24, 11017-11022.
102. Hodgson RJ and S Rachman (1977) Obsessional-compulsion complaints. Behav. Res. Ther. 15, 389-395.
103. Hoehn-Saric R and VC Barksdale (1983) Impulsiveness in obsessive-compulsive patients. Br. J. Psychiatry 143, 177-182.
104. Hollander E and CM Wong (1995) Obsessive-compulsive spectrum disorders. J. Clin. Psychiatry 56(Suppl. 4), 3-6.
105. Hollander E, JH Kwon, DJ Stein, J Broatch, CT Rowland and CA Himelein (1996) Obsessive-compulsive spectrum disorders: Overview and quality of life issues. J. Clin. Psychiatry 57(Suppl. 8), 3-6.
106. Hoptman MJ, J Volavka, G Johnson, E Weiss, RM Bilder and KO Lim (2002) Frontal white matter microstructure, aggression, and impulsivity in men with schizophrenia: A preliminary study. Biol. Psychiatry 52, 9-14.
107. Horesh N (2001) Self-report vs. computerised measures of impulsivity as a correlate of suicidal behavior. Crisis 22, 27-31.
108. Horn NR, M Dolan, R Elliott, JF Deakin and PW Woodruff (2003) Response inhibition and impulsivity: An fMRI study. Neuropsychologia 41, 1959-1966.
109. Houston RJ and MS Stanford (2001) Mid-latency evoked potential in self-reported impulsive aggression. Int. J. Psychophysiol. 40, 1-15.
110. Houston RJ and MS Stanford (2005) Electrophysiological substrates of impulsiveness: Potential effects on aggressive behavior. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 29, 305-313.
111. Huang N-Y and RM Kostrzewa (1994) Persistent oral dyskinesias in haloperidol-withdrawn neonatal 6-hydroxydopaminelesioned rats. Eur. J. Pharmacol. 253, 163-166.
112. 3H]raclopride binding to neostriatal homogenates. J. Pharmacol. Exp. Ther. 280, 268-276.
113. Huang W, Y Chen, E Shohami and M Weinstock (1999) Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse. Eur. J. Pharmacol. 366, 127-135.
114. Jobe PC, JW Dailey and JF Wernicke (1999) A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders. Crit. Rev. Neurobiol. 13, 317-356.
115. Kamali M, MA Oquendo and JJ Mann (2001) Understanding the neurobiology of suicidal behaviour. Depress. Anxiety 14, 164-176.
116. Kanner AM and A Balabanov (2002) Depression and epilepsy. How closely related are they? Neurology 58(Suppl. 5), S27-S39.
117. Kanner AM and S Palac (2000) Depression in epilepsy: A common but often unrecognized maladie. Epilepsy Behav. 1, 37-51.
118. Karilampi U, L Helldin, F Hjärthag, T Norlander and T Archer (2007) Verbal learning in schizopsychotic outpatients as a function of cognitive performance levels. Arch. Clin. Neuropsychol. 2007 Jan 20; [Epub ahead of print].
119. Karlsson E and T Archer (2007a) Relationship between personality characteristics and affect: Gender and affective personality. Individ. Differ. Res. (In press).
120. Karlsson E and T Archer (2007b) Affective state, stress and Type A-personality as a function of gender and affective personality. Pers Soc. Psychol. (In press).
121. Kashden J, WJ Fremouw, TS Callahan and MD Franzen (1993) Impulsivity in suicidal and nonsuicidal adolescents. J. Abnorm. Child Psychol. 21, 339-353.
122. Keilp JG, HA Sackeim, BS Brodsky, MA Oquendo, KM Malone and JJ Mann (2001) Neuropsychological dysfunction in depressed suicide attempters. Am. J. Psychiatry 158, 735-741.
123. Kiehl KA, AM Smith, RD Hare, A Mendrek, BB Forster, J Brink and PF Liddle (2001) Limbic abnormalities in affective processing by criminal psychopaths as revealed by functional magnetic resonance imaging. Biol. Psychiatry 50, 677-684.
124. Knowton BJ, JA Mangels and LR Squire (1996) A neostriatal habit learning system in humans. Science 273, 1399-1402.
125. Kostrzewa RM (1995) Dopamine receptor supersensitivity. Neurosci. Biobehav. Rev. 19, 1-17.
126. Kostrzewa RM, N-Y Huang, JP Kostrzewa, P Nowak and R Brus (2007) Modeling tardive dyskinesia: Predictive 5-HT(2C) receptor antagonist treatment. Neurotox. Res. 11, 41-50.
127. Krochmalik A, MK Jones and RG Menzies (2001) Danger Ideation Reduction Therapy (DIRT) for treatment-resistent compulsive washing. Behav. Res. Ther. 39, 897-912.
128. Kruger S, P Braunig, J Hoffer, G Shugar, I Bommer and J Langkrar (2000) Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms. J. Neuropsychiatr. Clin. Neurosci. 12, 16-24.
129. Krystal JH, DC D'Souza, J Gallinat, N Driesen, A Abi-Dargham, I Petrakis, A Heinz and G Pearlson (2006) The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia. Neurotox Res. 10(3,4), 235-252. Review.
130. Lacey JH and CDH EVans (1986) The impulsivist: A multiimpulsive personality disorder. Br. J. Addict. 81, 641-649.
131. Lahey BB, K McBurnett, R Loeber and EL Hart (1995) Psychobiology, In: Conduct Disorders in Children and Adults (Sholevar G, Ed.) (Am. Psychiatr. Press: Washington), pp. 27-44.
132. LaPierre D, CMJ Braun and S Hodgins (1995) Ventral frontal deficits in psychopathy: Neuropsychological test findings. Neuropsychologia 33, 139-151.
133. Leentjens AF (2004) Depression in Parkinson's disease: Conceptual issues and clinical challenges. J. Geriatr. Psychiatry Neurol. 17, 120-126.
134. Lejoyeux M, M Arbaretaz, M McLoughlin and J Ades (2002) Impulse control disorders and depression. J. Nerv. Ment. Disord. 190, 310-314.
135. Li CR and S-H Chen (2006) Obsessive-compulsiveness and impulsivity in a non-clinical population of adolescent males and females. Psychiatr. Res. (In press).
136. Links PS, R Heslegrave and R van Reekum (1999) Impulsivity: Core aspect of borderline personality disorder. J. Pers. Disord. 13, 1-9.
137. Lish JD, RJ Kavoussi and EF Coccaro (1996) Aggressiveness, In: Personality Characteristics of the Personality Disordered (Costello CG, Ed.) (Wiley: New York), pp. 24-47.
138. Lobo A, P Saz, G Marcos, R Campos, J Garcia-Campayo, F Orozco, M Barcones, A Capayo and A Sarasola (2005) Depressive co-morbidity in medical in-patients at the time of hospital discharge and outcome in a primary care follow-up. I Rational and design of the project. Eur. J. Psychiatry 19.
139. Lobo A, P Saz, G Marcos, A Sarasola, MF Barcones, A Bulbena, J De Pablo, JM Farré et al (2007) Depressive comorbidity in patients with somatic pathology, In: Comorbidity in Neuropsychiatric Disorders (Palomo T, RJ Beninger, RM Kostrzewa and T Archer, Eds.) (Fundacion Cerebro y Mente: Madrid) (In press).
140. Lykken D (1995) The Antisocial Personalities (Erlbaum: Hillsdale, NJ).
141. Lysaker PH, KA Marks, JB Picone, AI Rollins, PS Fastenau and GR Bond (2000) Obsessive and compulsive symptoms in schizophrenia. Clinical and neurocognitive correlates. J. Nerv. Ment. Dis. 188, 78-83.
142. Mann JJ (2003) Neurobiology of suicidal behavior. Nat. Rev. Neurosci. 4, 819-828.
143. Martins SS, H Tavares, DS da Silva Lobo, AM Galetti and V Gentil (2004) Pathological gambling, gender, and risk-taking behaviors. Addict. Behav. 29, 1231-1235.
144. Maser JD, HS Akiskal, P Schettler, W Scheftner, T Mueller, J Endicott, D Solomon and P Clayton (2002) Can temperament identify affectively ill patients who engage in lethal or near-lethal suicidal behavior? A 14-prospective study. Suicide Life-Threat. Behav. 32, 10-32.
145. Maslin J (2003) Substance misuse in psychosis: Contextual issues, In: Substance Misuse in Psychosis: Approaches to Treatment and Service Delivery (Graham H, A Copello, MJ Birchwood and K Mueser, Eds.), (Wiley: Chichester), pp. 108-126.
146. Mathias CW and MS Stanford (1999) P300 under standard and surprise conditions in self-reported impulsive aggression. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 23, 1037-1051.
147. Mathias CW and MS Stanford (2003) Impulsiveness and arousal: Heart rate under conditions of rest and challenge in healthy males. Pers. Individ. Differ. 35, 355-371.
148. Matsunaga H, N Kiriike, T Matsui, K Oya, K Okino and DJ Stein (2005) Impulsive disorders in Japanese adult patients with obsessive-compulsive disorder. Compr. Psychiatry 46, 43-49.
149. McCormick RA, J Taber, N Kruedelbach and A Russo (1987) Personality profiles of hospitalized pathological gamblers. J. Clin. Psychol. 43, 521-527.
150. McCreadie RG (2002) Use of drugs, alcohol and tobacco by people with schizophrenia: Case-control study. Br. J. Psychiatry 181, 321-325.
151. McDonald WM, IH Richard and MR DeLong (2003) Prevalence, etiology, and treatment of depression in Parkinson's disease. Biol. Psychiatry 54, 363-375.
152. McElroy SL, KA Phillips and PE Keck (1994) Obsessive compulsive spectrum disorder. J. Clin. Psychiatry 55(Suppl. 10), 33-51.
153. McEnroy SL, HG Pope, PE Keck and JI Hudson (1995) Disorders of impulsive control, In: Impulsivity and Aggression (Hollander E and D Stein, Eds.) (John Wiley and Sons: Sussex, UK), pp. 109-136.
154. Mehler-Wex C, P Riederer and M Gerlach (2006) Dopaminergic dysbalance in distinct basal ganglia neurocircuits: Implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder. Neurotox. Res. 10, 167-179, 2006.
155. Millet P (2005) Locus of control and its relation to working life: studies from the fields of vocational rehabilitation and small firms in Sweden. Doktorsavhandling, Arbetslivsinstitut, Luleås Tekniska Universitet [Doctoral Dissertation, Work Life Institute, Luleå Technical University].
156. Millet P and K Sandberg (2003) Locus of control and its relationship with rehabilitation outcomes of unemployed sick leavers in Sweden. J. Vocation. Rehab. 19, 59-66.
157. Moeller FG, ES Barratt, DM Dougherty, JM Schmitz and AC Swann (2001) Psychiatry aspects of impulsivity. Am. J. Psychiatry 158, 1783-1793.
158. Moeller FG, ES Barratt, CJ Fischer, DM Dougherty, EL Reilly, CW Mathias and AC Swann (2004) P300 event-related potential amplitude and impulsivity in cocaine-dependent subjects. Neuropsychobiol. 50, 167-173.
159. Molina V (2007) Atypical effects of atypicals in schizophrenia, In: Comorbidity in Neuropsychiatric Disorders (Palomo T, RJ Beninger, RM Kostrzewa and T Archer, Eds.) (Fundacion Cerebro y Mente: Madrid) (in press).
160. Molina V, S Reig, M Desco, JD Gispert, J Sanz, F Sarramea, J Pascau, C Benito, R Martinez-Lazaro, R Luque, M Aragues, JM Misiego, IL Corral and T Palomo (2002) Multimodality neuroimaging studies and the neurodevelopmental hypothesis of schizophrenia. Neurotox. Res. 4, 437-451.
161. Molina V, JD Gispert, S Reig, J Sanz, J Pascau, A Santos, T Palomo and M Desco (2003) Cerebral metabolism and risperidone treatment in schizophrenia. Schizophr. Res. 60, 1-7.
162. Molina V, JD Gispert, S Reig, J Pascau, R Martinez, J Sanz, T Palomo and M Desco (2005a) Olanzapine-induced cerebral metabolic changes. Relation to symptom changes in schizophrenia. Int. Clin. Psychopharmacol. 20, 13-18.
163. Molina V, JD Gispert, S Reig, J Pascau, A Santos, M Desco and T Palomo (2005b) Cerebral metabolic changes induced by clozapine in schizophrenia. Psychopharmacology 178, 17-26.
164. Molina V, F Sarramea, J Sanz, C Benito and T Palomo (2005c) Prefrontal atrophy in first episodes of schizophrenia associated with limbic hyperactivity. J. Psychiatr Res. 39, 117-127.
165. Molina V, S Reig, J Sanz, T Palomo, C Benito, J Sanchez, F Sarramea, J Pascau and M Desco (2005d) Increase in grey matter volume and decrease in white matter volume in the cerebral cortex during treatment with atypical neuroleptics in schizophrenia. Schizophr. Res. 80(1), 61-71.
166. Monterosso J and G Ainslie (1999) Beyond discounting: Possible experimental models of impulse control. Psychopharmacol. 146, 339-347.
167. Morgan MJ, LC Impallomeni, A Pirona and RD Rogers (2006) Elevated impulsivity and impaired decision-making in abstinent ecstasy (MDMA) users compared to polydrug and drugnaive controls. Neuropsychopharmacol. 31, 1562-1573.
168. Mori T, T Sasaki, A Iwanami, T Araki, K Mizuno, T Kato and N Kato (2003) Smoking habits in Japanese patients with schizophrenia. Psychiatr. Res. 120, 207-209.
169. Muller JL, M Sommer, V Wagner, K Lange, H Taschler, CH Röder, G Schuierer, HE Klein and G Hajak (2003) Abnormalities in emotion processing within cortical and subcortical regions in criminal psychopaths: Evidence from a functional magnetic resonance imaging study using pictures with emotional content. Biol. Psychiatry 54, 152-162.
170. Muller N, A Putz, N Kathmann, R Lehle, W Gunther and A Straube (1997) Characteristics of obsessive-compulsives symptoms in Tourette's syndrome, obsessive-compulsive disorder and Parkinson's disease. Psychiatr. Res. 70, 105-114.
171. Navas Collado E and JJ Munoz Garcia (2004) Disexecutive syndrome in psychopathy. Revista de Neurologia 38, 582-590.
172. Nordin C and T Eklundh (1999) Altered CSF 5-HIAA disposition in pathologic male gamblers. CNS Spectrums 4, 25-33.
173. Norlander T, S-A Bood and T Archer (2002) Performance during stress: affective personality, age, and regularity of physical exercise. Soc. Behav. Personal. Int. J. 30, 495-508.
174. O'Brien CP, DS Charney, L Lewis, JW Cornish, RM Post, GE Woody, JK Zubieta, JC Anthony, JD Blaine et al. (2004) Priority actions to improve the care of persons with cooccuring substance abuse and other mental disorders: A call to action. Biol. Psychiatry 56, 703-713.
175. O'Gorman JG and JEM Lloyd (1987) Extraversion, impulsiveness and EEG alpha activity. Pers. Individ. Differ. 8, 169-174.
176. Palomo T, RJ Beninger, RM Kostrzewa and T Archer (2004) Gene-environment interplay in affect and dementia: Emotional modulation of cognitive expression in personal outcomes. Neurotox. Res. 6, 159-173.
177. Paquet E, JP Soucy, E Stip, M Levesque, A Elie and MA Bedard (2004) Ccomparison between olanzapine and haloperidol on procedural learning and the relationship with striatal D-2 receptor occupancy in schizophrenia. J Neuropsychiatr. Clin. Neurosci. 16, 47-56.
178. Patrick CJ (1994) Emotion and psychopathy: Startling new insights. Psychophysiol. 31, 319-330.
179. Patton JH, MS Stanford and ES Barratt (1995) Factor structure of the Barratt Impulsiveness Scale. J. Clin. Psychol. 51, 768-774.
180. Peluso MAM, JP Hatch, DC Glahn, ES Monkul, M Sanches, P Najt, CL Bowden, ES Barratt and JC Soares (2006) Trait impulsivity with mood disorders. J. Affect. Disord. 2006 Nov 8; [Epub ahead of print].
181. Pencer A and J Addington (2003) Substance use and cognition in early psychosis. J. Psychiatr. Neurosci. 28, 48-54.
182. Peterson L, A Thorup, P Jeppesen, J Oehlenschlager, T Christensen, M-B Abel et al. (2002) Substance harm and dependence in first-episode psychosis. Acta Psychiatr. Scand. 106(Suppl 413), 22-35.
183. Pierri JN, AS Chaudry, TU Woo and DA Lewis (1999) Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am. J. Psychiatry 156, 1709-1719.
184. Plutchik R and HM van Praag (1995) The nature of impulsivity: definitions, ontology, genetics, and relations to aggression, In: Impulsivity and Aggression (Hollander E and DJ Stein, Eds.) (Wiley: New York), pp. 217-231.
185. Potenza MN, MA Steinberg, P Skudlarski, RK Fulbright, CM Lacadie, MK Wilber, BJ Rounsaville, JC Gore and BE Wexler (2003) Gambling urges in pathological gambling: A functional magnetic resonance imaging study. Arch. Gen. Psychiatry 60, 828-836.
186. Potts GF, MRM George, LE Martin and ES Barratt (2006) Reduced punishment sensitivity in neural systems of behavior monitoring in impulsive individuals. Neurosci. Lett. 397, 130-134.
187. Poyurovsky M, P Dorfman-Etrog, H Hermesh, H Munitz, GD Tollefson and A Weizman (2000) Beneficial effect of olanzepine in schizophrenic patients with obsessive-compulsive symptoms. Int. Clin. Psychopharmacol. 15, 169-173.
188. Quednow BB, KU Kuhn, R Stelzenmueller, K Hoenig, W Maier and M Wagner (2004) Effects of serotonergic and noradrenergic antidepressants on auditory startle responses in patients with major depression. Psychopharmacology 175, 399-406.
189. Raine A and F Jones (1987) Attention, autonomic arousal and personality in behaviorally disordered children. J. Abnorm. Child Psychol. 14, 583-599.
190. Raine A, MS Buchsbaum, J Stanley, S Lottenberg and AL Stoddard (1994) Selective reductions in prefrontal glucose metabolism in murderers. Biol. Psychiatry 36, 365-373.
191. Raine A, JR Meloy, S Bihrle, J Stoddard, L Lacasse and MS Buchsbaum (1998) Reduced prefrontal and increased subcortical brain functioning assessed using positron emission tomography in predatory and affective murderers. Behav. Sci. Law 16, 319-332.
192. Raine A, T Lencz, S Bihrle, L LaCasse and P Colletti (2000) Reduced prefrontal grey matter volume and reduced autonomic activity in antisocial personality disorder. Arch. Gen. Psychiatry 57, 119-127.
193. Rasmussen SA and JL Eisen (1994) The epidemiology and differential diagnosis of obsessive compulsive disorder. J. Clin. Psychiatry 55, 5-10.
194. Raust A, F Slama, F Mathieu, I Roy, A Chenu, D Koncke, D Fouques, F Jollant, E Jouvent, P Courtet, M Leboyer and F Belliver (2006) Prefrontal cortex dysfunction in patients with suicidal behavior. Psychol. Med. 37, 411-419.
195. Ray Li CS, SH Chen, WH Lin and YY Yang (2005) Attentional blink in adolescents with varying levels of impulsivity. J Psychiatr Res. 39(2), 197-205.
196. Reynolds B, A Örtengren and JB Richards (2006) Dimensions of impulsive behaviour: Personality and behavioural measures. Pers. Individ. Differ. 40, 305-315.
197. Robbins TW (2005) Chemistry of the mind: Neurochemical modulation of prefrontal cortical function. J. Comp. Neurol. 493, 140-146.
198. Robertson GS and HC Fibiger (1992) Neuroleptics increase c-fos expression in the forebrain: Contrasting effects of haloperidol and clozapine. Neuroscience 46, 315-328.
199. Robertson M (1987) Carbamazepine and depression. Int. J. Clin. Psychopharmacol. 2, 23-35.
200. Rodriguez-Jimenez R, C Avila, MA Jimenez-Arriero, G Ponce, R Monasor, M Jimenez, M Aragues, J Hoenicka, G Rubio and T Palomo (2006) Impulsivity and sustained attention in pathological gamblers: Influence of childhood ADHD history. J. Gambl. Stud. 22, 451-461.
201. Rotter JB (1966) Generalized expectancies for internal versus external control of reinforcement. Psychol. Monogr. 80, Nr. 609.
202. Sacco KA, A Termine, A Seyal, MM Dudas, JC Vessicchio, S Krishnan-Sarin, PI Jatlow, BE Wexler and TP George (2005) Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch. Gen. Psychiatry 62, 649-659.
203. Scarpe A and A Raine (1997) Psychophysiology of anger and violent behavior. Psychiatr. Clin. North Am. 20, 375-394.
204. Shih RA, PI Belmonte and PP Zandi (2004) A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders. Int. Rev. Psychiatry 16, 260-283.
205. Simeon D, E Hollander, DJ Stein, L Cohen and B Aronowitz (1995) Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder. Am. J. Psychiatry 152, 1207-1209.
206. Simpson MD, P Slater, JF Deakin, MC Royston and WJ Skan (1989) Reduced GABA uptake sites in the temporal lobe in schizophrenia. Neurosci. Lett. 107, 211-215.
207. Skodol AE and JM Oldham (1995) Phenomenology, differential diagnosis and comorbidity of the obsessive-compulsive spectrum disorder, In: Impulsivity and Aggression (Hollander E and DJ Stein, Eds.) (John Wiley and Sons: Sussex, UK), pp. 1-36.
208. Soloff PH, CC Meltzer, C Becker, PJ Greer, TM Kelly and D Constantine (2003) Impulsivity and prefrontal hypometabolism in borderline personality disorder. Psychiatr. Res. 123, 153-163.
209. Someya T, K Sakado, T Seki, M Kojima, C Reist, SW Tang and S Takahashi (2001) The Japanese version of the Barratt Impulsiveness Scale, 11th version (BIS-11): Its reliability and validity. Psychiatr. Clin. Neurosci. 55, 111-114.
210. Specker SM, GA Carlson, GA Christenson and M Marcotte (1995) Impulse control disoders and attention deficit disorder in pathological gamblers. Ann. Clin. Psychiatry 7, 175-179.
211. Spring B, R Pingitore and DE McChargue (2003) Reward value of cigarette smoking for comparably heavy smoking schizophrenic, depressed, and nonpatient smokers. Am. J. Psychiatry 160, 316-322.
212. Stein DJ, RL Trestman, V Mitropoulou, EF Coccaro, E Hollander and LJ Siever (1996) Impulsivity and serotonergic function in compulsive personality disorder. J. Neuropsychiatr. Clin. Neurosci. 8 393-398.
213. Stenberg G (1992) Personality and the EEG: Arousal and emotional arousability. Pers. Individ. Differ. 13, 1097-1113.
214. Sterling J, Y Herzig, T Goren, N Finkelstein, D Lerner, W Goldenberg, L Miskolczi, S Molnar, F Rantal et al. (2002) Novel dual inhibitors of AchE and MAO derived from hydroxy aminoindan and phenylethylamine as potential treatment for Alzheimer's disease. J. Med. Chem. 45, 5260-5279.
215. Stevens AA, PS Goldman-Rakic, JC Gore, RK Fulbright and BE Wexler (1998) Cortical dysfunction in schizophrenia during auditory word and tone working memory demonstrated by functional magnetic resonance imaging. Arch. Gen Psychiatry 55, 1097-1103.
216. Swann AC, JC Anderson, DM Dougherty and FG Moeller (2001) Measurement of inter-episode impulsivity in bipolar disorder. Psychiatr. Res. 101, 195-197.
217. Swann AC, P Pazzaglia, A Nicholls, DM Dougherty and FG Moeller (2003) Impulsivity and phase of illness in bipolar disorder. J. Affect. Disord. 23, 105-111.
218. Swann AC, DM Dougherty, P Pazzaglia, M Pham and FG Moeller (2004) Impulsivity: A link between bipolar disorder and substance abuse. Bipolar Disord. 6, 204-212.
219. Swann AC, DM Dougherty, P Pazzaglia, M Pham, JL Steinberg and FG Moeller (2005) Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder. Am. J. Psychiatry 162, 1680-1687.
220. Thompson RW and GT Nichols (1992) Correlations between scores on a continuous performancetest and parents/rs ratings of attention problems and impulsivity in children. Psychol. Rep. 70, 739-742.
221. Valdes IH, JL Steinberg, PA Narayana, LA Kramer, DM Dougherty, AC Swann, ES Barratt and FG Moeller (2006) Impulsivity and BOLD fMRI activation in MDMA-users and healthy control subjects. Psychiatr. Res.: Neuroimaging 147, 239-242.
222. Veazey C, SO Aki, KF Cook, EC Lai and ME Kunik (2005) Prevalence and treatment of depression in Parkinson's disease. J. Neuropsychiatr. Clin. Neurosci. 17, 310-323.
223. Vitacco MJ and R Rogers (2001) Predictors of adolescent psychopathy: The role of impulsivity, hyperactivity, and sensation seeking. J. Am. Acad. Psychiatr. Law 29, 374-382.
224. Volk DW, JN Pierri, JM Fritschy, S Auh, AR Sampson and DA Lewis (2002) Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb. Cortex 12, 1063-1070.
225. Völlm BA, P Richardson, J Stirling, R Elliott, M Dolan, I Chaudry, C Del Ben, S McKie, I Anderson and B Deakin (2004) Neurobiological substrates of antisocial and borderline personality disorder: preliminary results of a functional fMRI study. Crim. Behav. Ment. Health 14, 39-54.
226. Völlm BA, ANW Taylor, P Richardson, R Corcoran, J Stirling, S McKie, JFW Deakin and R Elliott (2006) Neuronal correlates of theory of mind and empathy: A functional magnetic imaging study in a nonverbal task. NeuroImage 29, 90-98.
227. Waddington JL (1990) Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: Phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology (Berl.) 101, 431-447.
228. Weinstock M, T Goren and MBH Youdim (2000a) Development of a novel neuroprotective drug (TV3326) for the treatment of Alzheimer's disease, with cholinesterase and monoamine oxidase inhibitory activities. Drug Dev. Res. 50, 216-222.
229. Weinstock M, C Bejar, RH Wang, T Poltyrev, A Gross, JP Finberg and MBH Youdim (2000b) TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxides inhibitory activities for the treatment of Alzheimer's disease. J. Neural Transm. 60, 157-169.
230. Weizman A, R Weizman, C Fuchs, A Frisch and M Poyurovsky (2007) Comorbidity of schizophrenia and OCD: Clinical aspects, neurobiology and treatment, In: Comorbidity in Neuropsychiatric Disorders (Palomo T, RJ Beninger, RM Kostrzewa and T Archer, Eds.) (Fundacion Cerebro y Mente: Madrid) (in press).
231. Widiger TA (1991) DSM-IV reviews of the personality disorders: introduction to special series. J. Pers. Disord. 5, 122-134.
232. Widiger TA (2005) Five factor model of personality disorder: Integrating science and practice. J. Res. Pers. 39, 67-83.
233. Wirtshafter D and KE Asin (2003) Effects of haloperidol and clozapine on fos expression in the primate striatum. NeuroReport 14, 2429-2432.
234. + toxicity in vivo. Ann NY Acad. Sci. 899, 255-261.
235. Youdim MBH (2003) Rasagiline: An anti-Parkinson drug with neuroprotective activity. Exp. Rev. Neurother. 3, 737-749.
236. Youdim MBH and JJ Buccafusco (2005) Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders. Trends Pharmacol. Sci. 26, 27-35.
237. Youdim MBH and M Weinstock (2002) Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug, TV3326, [(N-Propargyl-(3R)Aminoindan-5-YL)-ethyl-methylcarbamate]. Cell. Mol. Neurobiol. 21, 555-573.
238. Youdim MBH, A Gross and JPM Finberg (2001) Rasagiline [N-Propargyl-1R (+)-aminoindant], a selective and potent inhibitor of mitochondrial monoamine oxidase B. Br. J. Pharmacol. 132, 500-506.
239. Youdim MBH, W Maruyama and M Naoi (2005) Neuropharmacological, neuroprotective and amyloid precursor processing properties of selective MAO-B inhibitor antiparkinsonian drug, rasagiline. Drugs Today 41, 369-391.
240. Youdim MBH, T Amit, BO Weinreb and M Yogev-Falach (2006) Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs: Ladostigil. Neurotox. Res. 10, 1-11.
241. Ziedonis DM and K Trudeau (1997) Motivation to quit using substances among individuals with schizophrenia: Implications for a motivation-based treatment model. Schizophr. Bull. 23, 229-238.